| CAS No | Product Name | Molecular Formula |
|---|---|---|
| 2212021-83-3 | 5-((S)-2,2-dimethyltetrahydro-2H-pyran-4-yl)-1-((1S,2S)-2-methyl-1-(5-oxo-4,5-dihydro-1,2,4-oxadiazol-3-yl)cyclopropyl)-1H-indole-2-carboxylic acid | C22H25N3O5 |
| 2212022-57-4 | (S)-1-(4-Fluoro-1-methyl-1H-indazol-5-yl)-3-(2-(4-fluoro-3,5-dimethylphenyl)-4-methyl-4,5,6,7-tetrahydro-2H-pyrazolo[4,3-c]pyridin-3-yl)-1,3-dihydro-2H-imidazol-2-one hydrochloride | C26H26ClF2N7O |
| 2213398-75-3 | Ibrutinib Impurity 7 | C18H15N5O |
| 2216750-52-4 | Solifenacin EP Impurity D | C31H28N2O |
| 2216787-21-0 | 1,1'-Sulfinylbis[3-fluorobenzene] | C12H8F2OS |
| 2217657-09-3 | 1-(tert-Butyl)-3-chloronaphthalene | C14H15Cl |
| 2217657-10-6 | 2-(4-(tert-Butyl)naphthalen-2-yl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane | C20H27BO2 |
| 2218457-00-0 | 4,5-Dimethyl-2-(4-methyl-3-phenylphenyl)pyridine | C20H19N |
| 2221016-10-8 | 3-Bromo-5-methyl-1H-pyrazole-4-carboxylic acid ethyl ester | C7H9BrN2O2 |
| 2221812-26-4 | 2-(6-Bromo-2,3-dichlorophenyl)-1,3-dioxolane | C9H7BrCl2O2 |
| 2222058-99-1 | 9,9-Dimethyl-3-[4-(N-phenylanilino)phenyl]fluoren-2-amine | C33H28N2 |
| 2222114-22-7 | Thalidomide-Piperazine 5-fluoride | C17H17FN4O4 |
| 2222653-74-7 | 4-(6-Fluoropyridin-3-yl)-6-(2-hydroxy-2-methylpropoxy)pyrazolo[1,5-a]pyridine-3-carbonitrile | C17H15FN4O2 |
| 2222654-09-1 | 4-(6-Fluoropyridin-3-yl)-6-hydroxypyrazolo[1,5-a]pyridine-3-carbonitrile | C13H7FN4O |
| 2222690-89-1 | MorDalphos Pd G3 | C43H55N2O4PPdS |
| 2222755-14-6 | 4-[5-[6-[(6-Methoxy-3-pyridinyl)methyl]-3,6-diazabicyclo[3.1.1]hept-3-yl]-2-pyrazinyl]-6-[(2R)-2-morpholinylmethoxy]pyrazolo[1,5-a]pyridine-3-carbonitrile | C29H31N9O3 |
| 2222857-00-1 | N-(5-Bromo-2-methoxy-4-pyridinyl)-carbamic acid 1,1-dimethylethyl ester | C11H15BrN2O3 |
| 2222941-37-7 | Inobrodib | C30H32F2N4O3 |
| 2222970-00-3 | 2-Bromo-9,9-dimethyl-5-phenyl-9H-fluorene | C21H17Br |
| 2223677-58-3 | 1-[4-[(3-Chloro-4-fluorophenyl)amino]-7-[[(3S)-tetrahydro-3-furanyl]oxy]-6-quinazolinyl]-5-hydroxy-2-pyrrolidinone | C22H20ClFN4O4 |
| 2223677-60-7 | N-[4-[(3-Chloro-4-fluorophenyl)amino]-7-[[(3S)-tetrahydro-3-furanyl]oxy]-6-quinazolinyl]formamide | C19H16ClFN4O3 |
| 2223677-62-9 | (2E)-N-[4-[(3,4-Difluorophenyl)amino]-7-[[(3S)-tetrahydro-3-furanyl]oxy]-6-quinazolinyl]-4-(dimethylamino)-2-butenamide | C24H25F2N5O3 |
| 2223677-63-0 | Afatinib Impurity E | C24H25Cl2N5O3 |
| 2223677-64-1 | (2E)-N-[4-[(3-Chloro-4-fluorophenyl)amino]-7-[[(3S)-tetrahydro-3-furanyl]oxy]-6-quinazolinyl]-2-butenamide | C22H20ClFN4O3 |
| 2225909-61-3 | 8-Bromo-1-chlorodibenzo[b,d]furan | C12H6BrClO |
| 2225986-95-6 | N-[[2-[[[4-[Imino[[[(1-methylpentyl)oxy]carbonyl]amino]methyl]phenyl]amino]methyl]-1-methyl-1H-benzimidazol-5-yl]carbonyl]-N-2-pyridinyl-beta-alanine ethyl ester | C34H41N7O5 |
| 2226366-36-3 | Methy1 1-amino-3-(benzyloxy)-4-oxo-1,4-dihydropyridine-2-carboxylate | C14H14N2O4 |
| 2226413-61-0 | Rosuvastatin EP Impurity E | C38H46F2N6O9S2 |
| 2226413-62-1 | Rosuvastatin EP Impurity J | C38H44F2N6O8S2 |
| 2226517-76-4 | Sgc-gak-1 | C18H17BrN2O3 |
| 2226735-55-1 | (S)-6-(4-(5-(3,5-difluorophenyl)-4,5-dihydro-1H-pyrazole-1-carbonyl)piperidin-1-yl)pyrimidine-4-carbonitrile | C20H18F2N6O |
| 2226739-30-4 | 5-Chlorobiphenyl-2-boronic Acid | C12H10BClO2 |
| 2226916-90-9 | 7-Chlorodibenzofuran-1-ol | C12H7ClO2 |
| 2227103-37-7 | Osimertinib Acetyl impurity | C27H33N7O2 |
| 2227107-89-1 | 1,4-Dihydro-1-(6-methoxy-1H-benzimidazol-2-yl)-3,5-dimethyl-4-oxo-2-pyridinecarboxylic acid ammonium salt (1:1) | C16H14N3O4.NH4 |
| 2227197-98-8 | (S)-4,4-Difluoro-2-methylpiperidine hcl | C6H12ClF2N |
| 2227198-38-9 | (3S,6R)-2,2-difluoro-5-[(2-methylpropan-2-yl)oxycarbonyl]-5-azaspiro[2.4]heptane-6-carboxylic acid | C12H17F2NO4 |
| 2227199-17-7 | (S)-3-(Trifluoromethoxy)pyrrolidine hydrochloride | C5H9ClF3NO |
| 2227205-32-3 | 4,4-Difluorotetrahydro-2H-pyran-2-carboxylic acid | C6H8F2O3 |
| 2227206-03-1 | 1-(5-Methylpyrazin-2-yl)methanamine dihydrochloride | C6H11Cl2N3 |
| 2227252-55-1 | 2-[(4S)-1-[Tert-butoxy)carbonyl]-3,3-difluoropiperidin-4-yl]acetic acid | C12H19F2NO4 |
| 2227589-22-0 | 1-((3-Fluoro-4-(methylcarbamoyl)phenyl)amino)cyclobutanecarboxylic acid | C13H15FN2O3 |
| 2227589-23-1 | Methyl 1-((3-fluoro-4-(methylcarbamoyl)phenyl)amino)cyclobutanecarboxylate | C14H17FN2O3 |
| 2227741-18-4 | (3S)-3-{1-[(tert-butoxy)carbonyl]piperidin-4-yl}-3-hydroxypropanoic acid | C13H23NO5 |
| 2229657-81-0 | Parecoxib Impurity 36 | C19H18N2O4S |
| 2229714-16-1 | (S)-3-(1-Oxo-5-(piperazin-1-yl)isoindolin-2-yl)piperidine-2,6-dione benzenesulfonate | C23H26N4O6S |
| 2229752-36-5 | 2-Chloro-4-[4-(1-naphthalenyl)phenyl]-6-phenyl-1,3,5-triazine | C25H16ClN3 |
| 2229864-78-0 | 1-(3-Bromophenyl)dibenzo[b,d]furan | C18H11BrO |
| 2230198-02-2 | Danuglipron | C31H30FN5O4 |
| 2230200-74-3 | Methyl (S)-4-amino-3-((oxetan-2-ylmethyl)amino)benzoate | C12H16N2O3 |